Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy
BackgroundGlioblastoma (GBM) is the deadliest form of brain cancer, impacting both adults and children, marked by exceptionally high morbidity and mortality rates, even with current standard treatments such as surgery, radiation therapy, and chemotherapy. Therefore, there is a pressing need for new...
Saved in:
| Main Authors: | Julia Uffenorde, Mehran Hariri, Eleftherios Papalanis, Annika Staffas, Josefine Berg, Bo Stenerlöw, Hanna Berglund, Christer Malmberg, Diana Spiegelberg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1451156/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictive and Prognostic Significance of Molecular Biomarkers in Glioblastoma
by: Siddharth Shah, et al.
Published: (2024-11-01) -
Self-replicating recombinant virus-like particles of lentivirus proliferating in glioblastoma cells and normal human macrophages
by: Herman D. Moshkoff, et al.
Published: (2024-11-01) -
A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for Glioblastoma
by: Ioannis Ntafoulis, et al.
Published: (2024-12-01) -
Isavuconazole therapy of disseminated and encephalic Saprochaete capitata infection in an acute myeloid leukemia patient treated with midostaurin.
by: Salvatore Perrone, et al.
Published: (2020-04-01) -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
by: Maria Ilaria Del Principe, et al.
Published: (2014-11-01)